首页 | 本学科首页   官方微博 | 高级检索  
     

维持性血液透析患者高甲状旁腺素血症的临床治疗观察
引用本文:孙爱东. 维持性血液透析患者高甲状旁腺素血症的临床治疗观察[J]. 中国基层医药, 2010, 17(13): 2767-2768. DOI: 10.3760/cma.j.issn.1008-6706.2010.20.014
作者姓名:孙爱东
作者单位:乐山市人民医院肾内科,四川省乐山,614000;
摘    要:
Objective To investigate the effect of two different blood purification methods on serum parathyroid hormone(PTH) in chronic hemodialysis patients. Methods 101 patients were randomly divided into two groups:hemodialysis + hemoperfusion group( HD + HP group) and hemodiafiltration group( HDF group). Patients in HD + HP group were treated with resin absorptive devices combined hemodialysis, patients in HDF group treated with hemodiafiltration. Routine determination of serum phosphorus and radioimmunoassay of PTH level were carried out before and after treatment. Results HDF group and HP + HD group were effective for the removal of serum phosphorus,and the clearance rate was no significant difference(P >0. 05). HDF group and HP + HD group could all effectively eliminate the middle molecular substance PTH, but the clearance rate of HDF group was better than that of HP + HD group,the difference was statistically significant (P < 0. 05 ). Conclusion HDF could safely and effectively clear PTH and had better effect than HD + HP.

关 键 词:慢性肾功能衰竭   血液透析   血液透析滤过   血液灌流   甲状旁腺素   

Clinical study on hemodialysis patients with high PTH
SUN Ai-dong. Clinical study on hemodialysis patients with high PTH[J]. Chinese Journal of Primary Medicine and Pharmacy, 2010, 17(13): 2767-2768. DOI: 10.3760/cma.j.issn.1008-6706.2010.20.014
Authors:SUN Ai-dong
Abstract:
Keywords:Chronic renal failureHemodialysisHemodiafiltrationHemoper-fusionParathyroid hormone
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号